SynAgile

SynAgile offers DopaFuse, an infusion therapy to stabilize L-DOPA levels in the body for patients who suffer from Parkinson’s disease.

SynAgile is dedicated to transforming the treatment of L-DOPA-responsive motor and non-motor complications in patients with Parkinson's disease. Our novel drugs and routes of administration are designed to enable patients to achieve stable plasma L-DOPA concentrations, and to provide convenient, continuous dopaminergic stimulation.